Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial) (Q28193858)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: October 2002)

Language	Label	Description	Also known as
English	Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial)	scientific article (publication date: October 2002)

Statements

scholarly article

0 references

Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial) (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

Christopher P Cannon

1

0 references

language of work or name

0 references

publication date

1 October 2002

0 references

American Journal of Cardiology

0 references

90

0 references

7

0 references

760-2

0 references

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902606-1

7 January 2021

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902606-1

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902606-1

7 January 2021

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902606-1

7 January 2021

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902606-1

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902606-1

7 January 2021

Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902606-1

7 January 2021

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902606-1

7 January 2021

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902606-1

7 January 2021

Identifiers

10.1016/S0002-9149(02)02606-1

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28193858&oldid=1514880792"